Pulmonx Corp (LUNG): Enterprise Value to EBITDA Ratio
This chart of the current market value of Pulmonx Corporation (LUNG) demonstrates an EV/EBITDA of 0.00. Pulmonx Corporation (LUNG) supplies innovative emphysema therapy devices and possesses significant pricing power due to a lack of comparable alternatives. The business is betting on the expansion of the Zephyr system across US clinics, while valve production facilities operate efficiently by implementing assembly process automation.
Comprehensive metric breakdowns and analytics for Pulmonx Corp (LUNG)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
LUNG - Net Financial Result|Projected Future Earnings Pulmonx Corporation|LUNG - Price to Earnings Ratio|Forward P/E Multiple Pulmonx Corp|LUNG - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pulmonx Corporation|LUNG - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Pulmonx|LUNG - Earnings per share for the trailing year|Quarterly EPS earnings growth pulmonx.com|LUNG - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Pulmonx Corporation
- sales volume and revenue indicators:
Analysis of all company metrics:Pulmonx Corp. LUNG
For Pulmonx Corporation (LUNG), with its unique Zephyr valve patents and strict FDA oversight, the EV/EBITDA debt and operational load valuation metric serves as an indicator of how effectively the company capitalizes on its technological advantage. This metric correlates the total enterprise value with earnings before interest, taxes, depreciation, and amortization, allowing investors to assess the real value of assets regardless of accounting write-offs and debt burdens.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (conmed.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Biosciences (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode)|Enterprise Value to EBITDA Ratio Picard Medical PMI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc. SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Inc - EV/EBITDA Multiple|Company Value to EBITDA tactilemedical.com|SNWV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Outset Medical|ELMD (Electromed) - EV/EBITDA Multiple|LENSAR, Inc (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio Profound Medical PROF|EV/EBITDA Multiple BDMD (Baird Medical Investment Holdings)|EV/EBITDA Multiple EDAP TMS S.A. EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (TELA Bio Corp) - Enterprise Value to EBITDA Ratio|CytoSorbents Corp - Business Value to Operating Income Before Depreciation|SRTS (Sensus) - EV/EBITDA Multiple|Company Value to EBITDA Zynex Medical ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies Oxy B.H.N. Ltd. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio seastarmedical.com (ICU)|IRIDEX Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization strataskinsciences.com|Enterprise Value to EBITDA Ratio GlucoTrack, Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc. NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
